Clinical Trial Update: CK-0045 Proof-of-concept Study in Participants With Overweight / Obesity and Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-concept study of CK-0045 in adults with overweight/obesity and type 2 diabetes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• CK-0045

Snippet

Sponsor: Cytoki Pharma | Conditions: Type 2 Diabetes Mellitus (T2DM), Obesity and Overweight | Phase 2 | Status: TERMINATED